Vlad Bogin M.D., Facp

Vlad Bogin, MD, FACP has held various leadership positions throughout their career. Vlad is currently the CEO of Nobilis Therapeutics, a position they have held since January 2016. Prior to that, they were the CEO and Founder of Cromos Pharma, a contract research organization specializing in biopharmaceutical clinical outsourcing. Vlad started this role in August 2006, and it is ongoing. Additionally, they served as the Chairman of the Board of Directors and President of Medistem Inc from September 2010 to March 2014, leading the company through various milestones including clinical trials and a successful sale. In 2008, they held a role as a Director at Boehringer Ingelheim. Overall, Vlad Bogin has extensive experience in the biotech and pharmaceutical industries, with a focus on clinical research and leadership.

Vlad Bogin, MD, FACP, began their education journey in 1991 when they joined Yale University School of Medicine as a medical student. Vlad pursued their studies there for two years, until 1993, focusing on medicine as their field of study. Following this, from 1997 to 2001, Vlad Bogin attended the University of Rochester School of Medicine and Dentistry. During this period, they held the position of Resident and Chief Medical Resident, although the specific field of study is not indicated.